Koh Sato

Statistics

Publications

Citations

768

H-Index

Active since

1991

Affiliations

Chugai Pharma (United States)(Current)

The Cancer Institute Hospital

The University of Osaka

Tohoku University

Mochida Pharmaceutical (Japan)

Koh Sato is an author at Chugai Pharma (United States) specializing in parathyroid hormone-related protein signaling, molecular biology, and medicine.

Publications per year

1991–2009

Publications

Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.

Koh Sato, Masayuki Tsuchiya, José W. Saldanha et al. · PubMed · 1993 · 277 citations

Pharmacy, Oncology, Pharmacology +17

ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST‐1

Yuichi Hirata, Naoki Kimura, Koh Sato et al. · FEBS Letters · 1994 · 169 citations

Life Sciences, Biochemistry, Molecular Biology +6

Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen

Haruo Iguchi, Etsuro Onuma, Koh Sato et al. · International Journal of Cancer · 2001 · 63 citations

Medicine, Cancer Biology, Oncology +11

Human BST-1 Expressed on Myeloid Cells Functions as a Receptor Molecule

Yoshiki Okuyama, K. Ishihara, Naoki Kimura et al. · Biochemical and Biophysical Research Communications · 1996 · 55 citations

Life Sciences, Immunology, Molecular Biology +6

Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.

Hidemi Saito, Toshiaki Tsunenari, Etsuro Onuma et al. · PubMed · 2006 · 46 citations

Medicine, Cancer Biology, Oncology +16

1–5 of 12